Novocure Announces Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy in Pancreatic CancerBusiness Wire • 07/21/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/21/23
INVESTOR DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/19/23
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 07/18/23
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/17/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/13/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/12/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmAccesswire • 07/11/23
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 07/08/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 07/08/23
NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff CabraserBusiness Wire • 07/03/23
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 07/01/23
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of NovoCure Limited (NVCR) Investors and Encourages Investors to Contact the Firm Before August 18, 2023Business Wire • 06/30/23
NovoCure Limited (NVCR) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against NovoCure LimitedBusiness Wire • 06/27/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)Business Wire • 06/27/23
NVCR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 06/26/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)Business Wire • 06/26/23
ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 06/24/23
NVCR INVESTOR DEADLINE: NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 06/24/23
NOVOCURE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCRPRNewsWire • 06/24/23
Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC TodayBusiness Wire • 06/23/23
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) InvestorsBusiness Wire • 06/23/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) InvestorsBusiness Wire • 06/22/23
